Dear Nonmem users,
My question is about ETAPval. I am modelling a parent-metabolite data using
the 2-stage approach. After modelling the parent drug alone, parameter
estimates (for the parent) were fixed in the metabolite model and metabolite
parameters were estimated. All ETAPvalules for metabolite parameters were
acceptable > 0.2 and all metabolite model parameters were estimated precisely;
however, some of the ETAPvalues of parent drug parameters became < 0.05 while
they were acceptable when the parent drug was modelled alone.
Should ETAPvalues for parent parameters stay above the acceptable limit even if
the parameters are fixed or we care only about the ETAPvals for estimated
parameters only?
N.B. Simultaneous modelling of the parent-metabolite wasn't possible.
Thank you,
Ahmad Abuhelwa
Email:
[email protected]<mailto:[email protected]>
Mobile: +61 413118743
ETAPvalues
2 messages
2 people
Latest: Aug 31, 2015
Dear Ahmad,
The ETA P-value is one of the diagnostics available for modelers. What it means
and how important it is depends on your modeling objective and data. Having
said that, in this case it seems that you have fixed thetas and omegas but left
parent concentrations in the dataset. The lower ETA P-value indicates that the
parent posthoc ETA distribution has shifted away from zero. This most likely
means that your metabolite submodel has 'pulled' the parent posthoc away. You
might want to look at the parent posthoc graphs to further investigate how the
model shifted.
Generally speaking this could mean that the metabolite model has some mismatch
that is compensated by the parent etas. You might be able to update the
metabolite (or parent) model to avoid this. If needed, you could also use a
slightly different approach where you completely fix the parent model by
appending your original posthocs to your dataset and apply them as a fixed
input to the metabolite model and adjust. Afterwards you can see whether the
updated model has improved ETA P-values.
Hope this helps!
Best regards,
Jeroen
http://pd-value.com
[email protected]
@PD_value
+31 6 23118438
-- More value out of your data!
Quoted reply history
> Op 31 aug. 2015 om 03:18 heeft Abu Helwa, Ahmad Yousef Mohammad - abuay010
> <[email protected]> het volgende geschreven:
>
> Dear Nonmem users,
>
> My question is about ETAPval. I am modelling a parent-metabolite data using
> the 2-stage approach. After modelling the parent drug alone, parameter
> estimates (for the parent) were fixed in the metabolite model and metabolite
> parameters were estimated. All ETAPvalules for metabolite parameters were
> acceptable > 0.2 and all metabolite model parameters were estimated
> precisely; however, some of the ETAPvalues of parent drug parameters became <
> 0.05 while they were acceptable when the parent drug was modelled alone.
>
> Should ETAPvalues for parent parameters stay above the acceptable limit even
> if the parameters are fixed or we care only about the ETAPvals for estimated
> parameters only?
>
> N.B. Simultaneous modelling of the parent-metabolite wasn’t possible.
>
> Thank you,
>
> Ahmad Abuhelwa
> Email: [email protected]
> Mobile: +61 413118743
>